NovelStem International (NSTM) Accumulated Expenses (2010 - 2026)
NovelStem International (NSTM) posted Accumulated Expenses of $37,673 for Q2 2026, unchanged from $37,673 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
NovelStem International (NSTM) Accumulated Expenses (2010 - 2026) Analysis & Trends
Since Q4 2010, NovelStem International has reported Accumulated Expenses for 21 quarters.
- Annual Accumulated Expenses shows a four-year compound annual growth rate of -3.5% (FY2021 to FY2025).
- In prior years, NovelStem International's Accumulated Expenses was $68,576 in FY2024 (+62.4%), $42,223 in FY2023 (-3.3%), $43,673 in FY2022 (+0.6%) and $43,425 in FY2021.
- Quarterly Accumulated Expenses has run from a low of $37,673 in Q1 2025 to a high of $126,015 in Q3 2024 over five years.
- On a year-over-year basis, Accumulated Expenses increased in 1 of the last six quarters, with an average decline of 11.8%.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q4 2024, with growth of 62.4%; the weakest was Q3 2025, with a decline of 70.1%.
- According to Business Quant data, Accumulated Expenses for the three prior quarters was $37,673 (Q1 2026), $37,673 (Q4 2025) and $37,673 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | NovelStem International | 493,324.54 | 346,279.54 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37,673.00 |
| Mar 31, 2026 | 37,673.00 |
| Dec 31, 2025 | 37,673.00 |
| Sep 30, 2025 | 37,673.00 |
| Jun 30, 2025 | 37,673.00 |
| Mar 31, 2025 | 37,673.00 |
| Dec 31, 2024 | 68,576.00 |
| Sep 30, 2024 | 126,015.00 |
| Mar 31, 2024 | 45,974.00 |
| Dec 31, 2023 | 42,223.00 |
| Sep 30, 2023 | 97,200.00 |
| Jun 30, 2023 | 92,650.00 |
| Mar 31, 2023 | 37,673.00 |
| Dec 31, 2022 | 43,673.00 |
| Sep 30, 2022 | 64,172.00 |
| Dec 31, 2021 | 43,425.00 |
| Sep 30, 2013 | 964,164.00 |
| Jun 30, 2013 | 851,587.00 |
| Mar 31, 2013 | 677,321.00 |
| Dec 31, 2012 | 1.04 Mn |
API Access
NovelStem International Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NSTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "NSTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NSTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();